COMPREHENSIVE CLINICAL TRIAL
Journal of Drugs in Dermatology (JDD)Original, Peer-Review Article
Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing Anti-Aging Skin Care Regimen With Clinical, Histopathologic, Immunohistochemical, Photographic, and Ultrasound Evaluation Amy Taub MD, Vivian Bucay MD, Gregory Keller MD, Jay Williams PhD, and Darius Mehregan MD
Institutional Review Board (IRB) approval was obtained for this study and the study was performed using Good Clinical Practice Guidelines 21 as published by the U.S. Food and Drug Administration (FDA).
Clinical Power Trio:
A 3-product skin care regimen globally improves the visual appearance of aging skin without irritation, dryness, or inflammation.
“DefenAge results in profound improvements in the visible health and beauty of the skin that are readily apparent to even the untrained eye”… READ FULL PRESS RELEASE ►
READ THE FULL-TEXT CLINICAL ARTICLE in the Journal of Drugs in Dermatology (JDD) ►
Unrestricted complimentary access